Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 3

2(33.3%)

Phase 2

1(16.7%)

6Total

N/A(3)

Phase 3(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06849024Not ApplicableCompleted

Electrostimulation in Patients with Leg Ulcers

Role: lead

NCT05932979Phase 2Withdrawn

Effect of the Administration of L-arginine vs. Placebo in Patients Diagnosed With Presbyvestibulopathy.

Role: lead

NCT05712044Not ApplicableUnknown

Effect of Folic Acid on the Presentation of Nuclear Abnormalities in People With a History Drug Abuse

Role: lead

NCT04253860Phase 3Terminated

Effect of Transcutaneous Electrical Nerve Stimulation in Diabetic Neuropathy

Role: lead

NCT03374176Phase 3Completed

Efficacy of Amoxicillin-metronidazole Compared to Clindamycin in Patients With Periodontitis and Diabetes

Role: lead

NCT03770611Not ApplicableUnknown

Effect of Prebiotics and/or Probiotics on Uremic Toxins and Inflammation Markers in Peritoneal Dialysis Patients

Role: collaborator

All 6 trials loaded